← Back to all trials
Not Yet Recruiting
NCT05689242
Intravenous Nalbuphine Versus Intravenous Dexmedetomidine for Conscious Sedation in Patients Undergoing Colonoscopy
Conditions: Colonoscopy
Sex: All
Ages: 18 Years – 80 Years
Phase: PHASE4
Enrollment: 66
Sponsor: Assiut University
Summary
The aim of this study is to compare the sedative, analgesic effect and hemodynamic changes due to dexmedetomidine and nalbuphine during elective colonoscopy.
Eligibility Criteria
Inclusion Criteria:The subject is scheduled for elective colonoscopy.The subject is ≥ 18 years and ≤ 80 years.Both sexes.No obvious abnormalities in preoperative ECG, blood routine ,electrolytes, and other tests .ASA class 1-3.Exclusion Criteria:Subject is known or believed to be pregnant or lactating women.Patients allergic to α2-adrenergic agonist or sulfa drugsChronic Opioid Use (daily or almost daily use of opioids for > 3 months).Patients that are immunologically compromised, or receiving chronic steroids (>30 days), excluding inhalers.Sleep apnea syndrome or difficult airway.Patient known to be asthmatic or recent chest infection.Patients that are prisoners.Patient refusal.
Source: ClinicalTrials.gov (NCT05689242). StuddyBuddy aggregates publicly available trial information.